Randomized Phase II Study of Weekly Irinotecan/Carboplatin (ICb) With or Without Cetuximab (Erbitux) in Patients With Metastatic Breast Cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Carboplatin (Primary) ; Cetuximab (Primary) ; Irinotecan (Primary)
- Indications Advanced breast cancer; Male breast cancer
- Focus Therapeutic Use
- 15 Sep 2016 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016.
- 27 Sep 2015 Results (n=1) presented at the ASCO - Breast Cancer Symposium 2015
- 08 Jun 2011 Planned end date (Jun 2013) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History